Diabetes and osteoporosis.

scientific article published on August 2008

Diabetes and osteoporosis. is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1007/BF03324857
P698PubMed publication ID18852539

P50authorPaolo ToninQ42747028
Stefania MaggiQ114171748
P2093author name stringGaetano Crepaldi
Alois Saller
Giovanna Romanato
P2860cites workGlobal prevalence of diabetes: estimates for the year 2000 and projections for 2030Q27860575
Osteoblast-derived cells express functional glucose-dependent insulinotropic peptide receptorsQ28145693
Identifying bone-mass-related risk factors for fracture to guide bone densitometry measurements: a systematic review of the literatureQ30765771
Worldwide increase in incidence of Type I diabetes--the analysis of the data on published incidence trendsQ31473026
Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspectiveQ33913377
Osteoprotegerin ligand: a regulator of immune responses and bone physiology.Q34079327
Who has osteoporosis? A conflict between clinical and public health perspectivesQ34111545
Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group.Q34319046
Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.Q34466568
Role of adipose tissue as an inflammatory organ in human diseasesQ34523574
Long-term bone loss in insulin-dependent diabetes mellitusQ34589435
Bone is a target for the antidiabetic compound rosiglitazone.Q35758012
Adipose tissue, inflammation, and cardiovascular diseaseQ36125401
Potential role of pancreatic and enteric hormones in regulating bone turnover.Q36214176
Rising incidence of insulin dependent diabetes in children aged under 5 years in the Oxford region: time trend analysis. The Bart's-Oxford Study GroupQ36246394
Is insulin an anabolic agent in bone? Dissecting the diabetic bone for cluesQ36281802
Osteoporosis in type II diabetesQ36457241
HMG-CoA reductase inhibitors and the risk of fracturesQ38496425
Quantitative heel ultrasound in a population-based study in Italy and its relationship with fracture history: the ESOPO studyQ38513084
Osteopenia and diabetes.Q39487558
The hypercalciuria of diabetes mellitus: its amelioration with insulinQ40188776
Transgenic mice with osteoblast-targeted insulin-like growth factor-I show increased bone remodelingQ40286652
Mosaic analysis of insulin receptor functionQ40413498
World-wide projections for hip fractureQ40909953
Effects of Diabetes Mellitus on Bone Mass in Juvenile and Adult-Onset DiabetesQ41076132
Bone mineral density and bone metabolism in diabetes mellitusQ41710701
Epidemiology of hip fracturesQ41717622
Bone mineral density at time of clinical diagnosis of adult-onset type 1 diabetes mellitusQ42510908
Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis FoundationQ43583991
Decreased bone mineral density and bone formation markers shortly after diagnosis of clinical type 1 diabetes mellitus.Q43630701
Diabetes and risk of fracture: The Blue Mountains Eye StudyQ43651870
Prevalence of low femoral bone density in older U.S. adults from NHANES III.Q44113237
Role of gastrointestinal hormones in postprandial reduction of bone resorptionQ44691059
Body composition and bone mineral density in long-standing type 1 diabetesQ44761590
Risk factors and health determinants in older ItaliansQ44887368
Osteopenia in insulin treated diabetes mellitus. Its relation to age at onset, sex and duration of diseaseQ45026095
Diabetes mellitus and the incidence of hip fracture: results from the Nord-Trøndelag Health SurveyQ45058945
Bone mineral density in children and adolescents with diabetes mellitus type 1 of recent onsetQ45238101
Sex differences in osteoporosis in older adults with non-insulin-dependent diabetes mellitusQ45937461
Bone mineral metabolism is normal in non-insulin-dependent diabetes mellitusQ46293407
Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patientsQ46413037
Older women with diabetes have an increased risk of fracture: a prospective studyQ46556380
Glucose-dependent insulinotropic peptide is an integrative hormone with osteotropic effects.Q48866872
Increase in incidence of insulin-dependent diabetes mellitus among children in Finland.Q50610289
Bone mineral density and blood flow to the lower extremities: the study of osteoporotic fractures.Q50619843
Analysis of 20 years of prospective registration of childhood onset diabetes time trends and birth cohort effects. Swedish Childhood Diabetes Study Group.Q50667674
Trends in the incidence of childhood-onset diabetes in Europe 1989-1998.Q50687950
Prospective bone mineral density evaluation in patients with insulin-dependent diabetes mellitus.Q50883815
Increasing serum osteocalcin after glycemic control in diabetic men.Q51584402
The association of obesity and glucose and insulin concentrations with bone density in premenopausal and postmenopausal women.Q51600199
An evaluation of bone density and turnover in premenopausal women with type 1 diabetes mellitus.Q51601847
The relationships of concentrations of insulin, intact proinsulin and 32-33 split proinsulin with cardiovascular risk factors in type 2 (non-insulin-dependent) diabetic subjects.Q51614436
Bone Density in Non-Insulin-Dependent Diabetes Mellitus: The Rotterdam StudyQ57388854
Leptin Inhibits Osteoclast GenerationQ57533678
Letters to the EditorsQ58868275
P433issue4
P921main subjectosteoporosisQ165328
P304page(s)280-289
P577publication date2008-08-01
P1433published inAging Clinical and Experimental ResearchQ15754191
P1476titleDiabetes and osteoporosis
P478volume20

Reverse relations

cites work (P2860)
Q35955946Alteration of vitamin D metabolic enzyme expression and calcium transporter abundance in kidney involved in type 1 diabetes-induced bone loss
Q89516735Antidiabetic and antiosteoporotic pharmacotherapies for prevention and treatment of type 2 diabetes-induced bone disease: protocol for two network meta-analyses
Q36028626Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies
Q37319080Association between osteoprotegerin G1181C and T245G polymorphisms and diabetic charcot neuroarthropathy: a case-control study
Q41733140Association of haematological parameters with bone mineral density in elderly diabetic women
Q35137241Diabetes reduces mesenchymal stem cells in fracture healing through a TNFα-mediated mechanism
Q51298932Effect of exenatide, insulin and pioglitazone on bone metabolism in patients with newly diagnosed type 2 diabetes.
Q96432958Effects of Glycated Hemoglobin Level on Bone Metabolism Biomarkers in Patients with Type 2 Diabetes Mellitus
Q35212798Elevated incidence of fractures in solid-organ transplant recipients on glucocorticoid-sparing immunosuppressive regimens
Q52702566Imaging of diabetic bone.
Q28567293Insulin receptor substrate 2 plays important roles in 17beta-estradiol-induced bone formation
Q37899709Osteoporosis and risk of fracture in patients with diabetes: an update
Q36582730Prevalence of Osteoporosis and Its Associated Factors among Older Men with Type 2 Diabetes
Q58588725The Effects of Soy Milk Enriched with Lactobacillus casei and Omega-3 on the Tibia and L5 Vertebra in Diabetic Rats: a Stereological Study
Q38233593The prevention of fragility fractures in diabetic patients.